Yuan J, Knorr J, Altmannsberger M, Goeckenjan G, Ahr A, Scharl A, Strebhardt K
Department of Obstetrics and Gynecology, School of Medicine, J. W. Goethe-Universität, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
J Pathol. 1999 Nov;189(3):358-62. doi: 10.1002/(SICI)1096-9896(199911)189:3<358::AID-PATH452>3.0.CO;2-1.
The retinoblastoma protein (pRB), p16, and cyclin D1 are major components of the RB pathway, which controls the G1 checkpoint of the cell cycle. Proper regulation of this pathway is crucial for normal cell proliferation. Abnormal forms of these proteins have been found in various types of malignant tumours. In the present report, immunohistochemical techniques were applied to study the expression of pRB, p16, and cyclin D1 in 161 samples of primary small cell lung cancer (SCLC) and 20 samples of non-small cell lung cancer (NSCLC). While pRB and cyclin D1 staining was negative in 161 specimens of SCLC, expression of p16 was observed in 153 samples. In contrast to SCLC, 16 out of 20 NSCLC cases exhibited pRB expression and 15 showed cyclin D1 expression, but only very weak p16 staining was found in five samples. These observations could provide additional criteria for the distinction between SCLC and NSCLC. Furthermore, these findings, based on primary tissues, implicate different mechanisms in the tumourigenesis of SCLC and NSCLC.
视网膜母细胞瘤蛋白(pRB)、p16和细胞周期蛋白D1是RB通路的主要组成部分,该通路控制细胞周期的G1期检查点。对这一通路的恰当调控对正常细胞增殖至关重要。在各类恶性肿瘤中均发现了这些蛋白的异常形式。在本报告中,应用免疫组化技术研究了161例原发性小细胞肺癌(SCLC)样本和20例非小细胞肺癌(NSCLC)样本中pRB、p16和细胞周期蛋白D1的表达情况。在161例SCLC标本中,pRB和细胞周期蛋白D1染色均为阴性,而在153个样本中观察到了p16的表达。与SCLC不同,20例NSCLC病例中有16例表现出pRB表达,15例表现出细胞周期蛋白D1表达,但仅在5个样本中发现了非常微弱的p16染色。这些观察结果可为区分SCLC和NSCLC提供额外标准。此外,这些基于原发组织的发现提示SCLC和NSCLC的肿瘤发生机制不同。